696 related articles for article (PubMed ID: 22002579)
1. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
Tejeda HA; Shippenberg TS; Henriksson R
Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin/KOP and nociceptin/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens.
Caputi FF; Di Benedetto M; Carretta D; Bastias del Carmen Candia S; D'Addario C; Cavina C; Candeletti S; Romualdi P
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():36-46. PubMed ID: 24184686
[TBL] [Abstract][Full Text] [Related]
3. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.
Tejeda HA; Bonci A
Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022
[TBL] [Abstract][Full Text] [Related]
4. κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.
Butelman ER; Yuferov V; Kreek MJ
Trends Neurosci; 2012 Oct; 35(10):587-96. PubMed ID: 22709632
[TBL] [Abstract][Full Text] [Related]
5. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.
Jamensky NT; Gianoulakis C
Alcohol Clin Exp Res; 1997 Nov; 21(8):1455-64. PubMed ID: 9394118
[TBL] [Abstract][Full Text] [Related]
6. The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?
Shippenberg TS
Neuropsychopharmacology; 2009 Jan; 34(1):247. PubMed ID: 19079072
[No Abstract] [Full Text] [Related]
7. Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain.
Wang XM; Zhou Y; Spangler R; Ho A; Han JS; Kreek MJ
Brain Res Mol Brain Res; 1999 Mar; 66(1-2):184-7. PubMed ID: 10095091
[TBL] [Abstract][Full Text] [Related]
8. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.
Mendizábal V; Zimmer A; Maldonado R
Neuropsychopharmacology; 2006 Sep; 31(9):1957-66. PubMed ID: 16292318
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
Steiner H; Gerfen CR
J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
[TBL] [Abstract][Full Text] [Related]
10. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
Bruchas MR; Land BB; Chavkin C
Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
[TBL] [Abstract][Full Text] [Related]
11. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S; Koob GF
Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
[TBL] [Abstract][Full Text] [Related]
12. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
Anderson RI; Becker HC
Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
[TBL] [Abstract][Full Text] [Related]
13. Kappa Opioids, Salvinorin A and Major Depressive Disorder.
Taylor GT; Manzella F
Curr Neuropharmacol; 2016; 14(2):165-76. PubMed ID: 26903446
[TBL] [Abstract][Full Text] [Related]
14. Further studies on possible dynorphin involvement in the ovulatory luteinizing hormone surge in the proestrous rat.
Zhang Q; McCoy JM; Gallo RV
Endocrine; 2002 Aug; 18(3):231-8. PubMed ID: 12450314
[TBL] [Abstract][Full Text] [Related]
15. Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.
Ventura C; Pintus G
J Biol Chem; 1997 Mar; 272(10):6699-705. PubMed ID: 9045702
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin activation of kappa opioid receptor protects against epilepsy and seizure-induced brain injury via PI3K/Akt/Nrf2/HO-1 pathway.
Dai H; Wang P; Mao H; Mao X; Tan S; Chen Z
Cell Cycle; 2019 Jan; 18(2):226-237. PubMed ID: 30595095
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.
Bazov I; Sarkisyan D; Kononenko O; Watanabe H; Yakovleva T; Hansson AC; Sommer WH; Spanagel R; Bakalkin G
Mol Neurobiol; 2018 Aug; 55(8):7049-7061. PubMed ID: 29383684
[TBL] [Abstract][Full Text] [Related]
18. Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.
D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
Neuroscience; 2007 Jan; 144(1):157-64. PubMed ID: 17055175
[TBL] [Abstract][Full Text] [Related]
19. Short-term withdrawal from repeated exposure to cocaine during adolescence modulates dynorphin mRNA levels and BDNF signaling in the rat nucleus accumbens.
Caputi FF; Caffino L; Candeletti S; Fumagalli F; Romualdi P
Drug Alcohol Depend; 2019 Apr; 197():127-133. PubMed ID: 30818133
[TBL] [Abstract][Full Text] [Related]
20. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
Carlezon WA; Krystal AD
Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
